This trial is active, not recruiting.

Conditions gestational diabetes, pregnancy, obesity
Sponsor MetroHealth Medical Center
Collaborator Centers for Disease Control and Prevention
Start date October 2012
End date May 2016
Trial size 150 participants
Trial identifier NCT02082301, MH-IRB12-00581


This is an observation study of women with gestational diabetes. Subjects recruited undergo immediate postpartum diabetic screening prior to discharge. Post-partum screening for overt diabetes is repeated 6-12 weeks postpartum. The outcome of interest is the utility of an immediate post partum screen for overt diabetes compared to a traditional 6 week test.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective
Primary cohort is women with diagnosis of gestational diabetes without evidence of overt diabetes

Primary Outcomes

Primary outcome: sensitivity of immediate post partum screen
time frame: Immediate post partum

Secondary Outcomes

Secondary outcome: physiology
time frame: 3 time points: antepatum, immediate postpartum, 6 weeks post partum

Eligibility Criteria

Female participants at least 18 years old.

Inclusion Criteria: - Singleton pregnancy - Gestational diabetes Exclusion Criteria: - Multiple gestations - pre-pregnancy diabetes

Additional Information

Official title Oral Glucose Tolerance Testing After Gestational Diabetes
Principal investigator Thaddeus Waters, MD
Trial information was received from ClinicalTrials.gov and was last updated in April 2015.
Information provided to ClinicalTrials.gov by MetroHealth Medical Center.